Frontiers in Immunology (Dec 2022)
Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
- Qiang Feng,
- Qiang Feng,
- Baozhen Sun,
- Tianyi Xue,
- Tianyi Xue,
- Rong Li,
- Chao Lin,
- Yongjian Gao,
- Liqun Sun,
- Yue Zhuo,
- Dongxu Wang
Affiliations
- Qiang Feng
- Department of Hepatobiliary and Pancreas Surgery, China - Japan Union Hospital of Jilin University, Changchun, China
- Qiang Feng
- Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China
- Baozhen Sun
- Department of Hepatobiliary and Pancreas Surgery, China - Japan Union Hospital of Jilin University, Changchun, China
- Tianyi Xue
- Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China
- Tianyi Xue
- School of Acupuncture-Moxi bustion and Tuina, Changchun University of Chinese Medicine, Changchun, China
- Rong Li
- Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China
- Chao Lin
- School of Grain Science and Technology, Jilin Business and Technology College, Changchun, China
- Yongjian Gao
- Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
- Liqun Sun
- Department of Pathogenobiology, Jilin University Mycology Research Center, College of Basic Medical Sciences, Jilin University, Changchun, China
- Yue Zhuo
- School of Acupuncture-Moxi bustion and Tuina, Changchun University of Chinese Medicine, Changchun, China
- Dongxu Wang
- Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China
- DOI
- https://doi.org/10.3389/fimmu.2022.1082984
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
